Location
United States, North America
Cheque size
$100K - $5M
Investment Stage
Series A
Focus Areas
Health IT
Health & Hospital Services
BioTech
Medical Devices
About Investor
Carlo Rizzuto, Ph.D., is a Partner at Versant Ventures based in New York City. He focuses on biotech and pharmaceuticals, typically at Series A and Series B, with a published range of $100K - $5.0M. Since joining the firm in 2012, he has helped build and invest in companies including Pandion, Repare, Century Therapeutics, Graphite Bio, Jnana, 858 Therapeutics, and Stablix, and he has been instrumental in establishing Versant’s presence in the Northeast.
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,JR
JJ Richa
United States, North America
$50K - $1M
Pre Seed
,Seed
,AL
Alicia Lenis
Canada, North America
$500K - $2M
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.